The cost of the newly approved treatment will be about $56,000 a year, much of it paid for by Medicare.
Everything needed for the test — which the FDA gave emergency authorization — is inside the box, except for a smartphone.
Moderna is just behind Pfizer and its German partner BioNTech in seeking to begin vaccinations in the U.S. in December.
Emergency authorization means the FDA facilitates availability of the vaccine during a declared state of emergency.
The concern is that it could be returning false negative results.
A rise in domestic violence, a decline in car accidents and more.
While identifying lost flavor genes and bringing them back has been tricky, some scientists are determined.
A combination of ingredients may cause potentially life-threatening electrical malfunctions in the heart.
Industry analysts expect the price for the single-treatment therapy to be anywhere from $1.5 million to $5 million.
Is the tech IPO resurgence at risk?